Pearl River Capital, LLC Abbott Laboratories Transaction History

Pearl River Capital, LLC

$0
Q4 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $1.44 Million - $1.6 Million	-14,272 Reduced 77.69%	4,098 $425,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $2.01 Million - $2.22 Million	18,370 New	18,370 $2.09 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $3.62 Million - $4.35 Million	37,941 Added 469.39%	46,024 $4.46 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $6.76 Million - $7.53 Million	-67,084 Reduced 89.25%	8,083 $881,000
Q1 2023 Dec 19, 2024	BUY	$96.86 - $114.01 $7.28 Million - $8.57 Million	75,167 New	75,167 $7.61 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $4.78 Million - $5.62 Million	49,332 Added 190.95%	75,167 $7.61 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $765,328 - $897,847	8,051 Added 45.27%	25,835 $2.84 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.72 Million - $1.99 Million	17,784 New	17,784 $1.72 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $3.56 Million - $4.3 Million	-34,889 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $3.46 Million - $4.22 Million	30,380 Added 673.76%	34,889 $4.13 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $1.82 Million - $2.23 Million	-15,768 Reduced 77.76%	4,509 $635,000
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $2.37 Million - $2.62 Million	20,277 New	20,277 $2.4 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $789,616 - $929,491	-7,464 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $812,381 - $957,108	7,464 New	7,464 $894,000
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $2.01 Million - $2.44 Million	-21,966 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $1.68 Million - $2.15 Million	21,966 New	21,966 $2.01 Million
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $408,958 - $598,008	-6,510 Closed	0 $0
Q4 2019 Feb 26, 2020	BUY	$78.51 - $87.4 $511,100 - $568,974	6,510 New	6,510 $565,000
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $39,528 - $42,861	-483 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $35,201 - $41,055	483 New	483 $41,000

Others Institutions Holding ABT

# of Institutions

3,336

Shares Held

1.36B

Call Options Held

10M

Put Options Held

9.48M

Vanguard Group Inc Valley Forge, PA

169M
Shares

$22 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$17.1 Billion
0.31% of portfolio
State Street Corp Boston, MA

77.2M
Shares

$10.1 Billion
0.35% of portfolio
Capital International Investors Los Angeles, CA

68M
Shares

$8.88 Billion
1.51% of portfolio
Capital Research Global Investors Los Angeles, CA

54.1M
Shares

$7.07 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.

Account